phase i clinical collaboration agreement , page-3

Kavafis, yep this one is still dawdling a little, although I feel in % terms this is a stock in the bio sector that could really prove to be the dark horse of the pack......You've got a new CEO, whom I am hearing very good things of, a change of the guard and a concerted effort to get this Cuprindo drug, and the company back into positive territory......You've got to admit, Mondays news announcement was a very positive step in the right direction, albeit the SP has not co-operated yet....but if this one in time comes screaming out of the ranks, I think it'll all make sense.